Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study
for the Global NEO-ASP Study Group
Research output
:
Contribution to journal
›
Article
›
peer-review
44
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Neonatal Intensive Care Unit
100%
Antiinfective Agent
87%
Antibiotics
50%
Culture
50%
Infection
37%
Infant
37%
Prevalence
25%
Vancomycin
25%
Sepsis
25%
Treatment Duration
25%
Amikacin
25%
Birth Weight
25%
Meropenem
25%
Antifungal Agent
12%
Diagnosis
12%
Ampicillin
12%
Antibiotic Therapy
12%
Gentamicin
12%
Exercise
12%
Hospital Mortality
12%
Antivirus Agent
12%
Antimicrobial Therapy
12%
Gestational Age
12%
Mortality
12%
Age
12%
Therapeutic Procedure
12%
Assessment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
87%
Infection
37%
Prevalence
25%
Vancomycin
25%
Sepsis
25%
Amikacin
25%
Meropenem
25%
Ampicillin
12%
Gentamicin
12%
Antibiotic Agent
12%
Hospital Mortality
12%
Antivirus Agent
12%
Mortality
12%
Antimicrobial Therapy
12%